Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
Open-market buys, last 90 days
$99,331
in 1 filing
Open-market sales, last 90 days
$297,289
in 4 filings, $297K under 10b5-1 plans

Net −$197,958. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-12-02 BRATTON DOUGLAS K 10% owner Gift −40,000 199,841
2021-03-12 BRATTON DOUGLAS K 10% owner Other disposition −524,675 1,688,639
2021-03-12 BRATTON DOUGLAS K 10% owner Other disposition −564,160 3,468,747
2021-03-12 BRATTON DOUGLAS K 10% owner Other disposition −97,598 2,657,943
2021-03-12 BRATTON DOUGLAS K 10% owner Other disposition −40,404 47,051
2021-03-12 BRATTON DOUGLAS K 10% owner Other disposition −2,249,077 0
2021-03-12 BRATTON DOUGLAS K 10% owner Other acquisition +1,783,578 1,948,578
2021-03-09 BRATTON DOUGLAS K 10% owner Gift −62,500 12,585
2020-06-16 BRATTON DOUGLAS K Director Grant or award · Stock Option (Right to Purchase) +14,000 14,000
2019-06-13 BRATTON DOUGLAS K Director Grant or award · Stock Option (Right to Purchase) +13,350 13,350
2018-07-24 BRATTON DOUGLAS K Director Grant or award · Stock Option (Right to Purchase) +26,700 26,700
2018-07-24 BRATTON DOUGLAS K Director Purchase +165,000 $15.00 $2.5M 165,000

Page 1 of 1 · 12 trades